Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 3, 2015Blood

Durable Remissions in Children with Relapsed/Refractory ALL Treated with T Cells Engineered with a CD19-Targeted Chimeric Antigen Receptor (CTL019)

View Full Paper
Ask AI
Bookmark
Share

Authors

SGStephan A. GruppSMShannon L. MaudePSPamela A. Shaw

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Grupp et al. (2015) studied this question.

synapsesocial.com/papers/6a0873541e0fcf4a43e8c7d0https://doi.org/10.1182/blood.v126.23.681.681
View Full Paper
Ask AI
Bookmark
Share